HUP0301099A3 - Substituted phthalocyanines and their precursors - Google Patents

Substituted phthalocyanines and their precursors

Info

Publication number
HUP0301099A3
HUP0301099A3 HU0301099A HUP0301099A HUP0301099A3 HU P0301099 A3 HUP0301099 A3 HU P0301099A3 HU 0301099 A HU0301099 A HU 0301099A HU P0301099 A HUP0301099 A HU P0301099A HU P0301099 A3 HUP0301099 A3 HU P0301099A3
Authority
HU
Hungary
Prior art keywords
precursors
substituted phthalocyanines
phthalocyanines
substituted
Prior art date
Application number
HU0301099A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Gentian As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by Gentian As filed Critical Gentian As
Publication of HUP0301099A2 publication Critical patent/HUP0301099A2/hu
Publication of HUP0301099A3 publication Critical patent/HUP0301099A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0301099A 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors HUP0301099A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (2)

Publication Number Publication Date
HUP0301099A2 HUP0301099A2 (hu) 2003-08-28
HUP0301099A3 true HUP0301099A3 (en) 2003-11-28

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301099A HUP0301099A3 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Country Status (10)

Country Link
EP (1) EP1238016A1 (no)
JP (1) JP2003516421A (no)
AU (1) AU2192201A (no)
CA (1) CA2394891A1 (no)
CZ (1) CZ20021974A3 (no)
EE (1) EE200200298A (no)
HU (1) HUP0301099A3 (no)
NO (1) NO20022663L (no)
PL (1) PL355851A1 (no)
WO (1) WO2001042368A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1381611T3 (da) * 2001-03-21 2005-10-24 Molteni & C Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik
EP1346971B1 (en) 2002-03-18 2010-01-20 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (zh) * 2003-02-11 2008-09-03 杜锡光 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途
DE602004021591D1 (de) * 2003-05-14 2009-07-30 Univ Sherbrooke Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung
JP4809657B2 (ja) * 2005-09-29 2011-11-09 富士フイルム株式会社 ナフタロシアニン色素およびその製造方法
JP4942351B2 (ja) * 2006-01-31 2012-05-30 独立行政法人科学技術振興機構 光線力学治療抗癌剤
JP5296355B2 (ja) * 2007-09-11 2013-09-25 株式会社日本触媒 アリール基含有フタロシアニン化合物、その製造方法、及び、配合物
US8168359B2 (en) * 2008-03-10 2012-05-01 Xerox Corporation Nanosized particles of phthalocyanine pigments
CZ303612B6 (cs) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny
JP2012167189A (ja) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池
JP2013193956A (ja) * 2012-03-15 2013-09-30 Saitama Univ ｔｅｔｒａｋｉｓ−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法
JP6278386B2 (ja) * 2013-11-06 2018-02-14 国立研究開発法人産業技術総合研究所 フタロシアニン化合物及び有機半導体材料
CN103864645B (zh) * 2013-12-30 2016-08-17 常州大学 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法
CN104016995A (zh) * 2014-06-26 2014-09-03 常州大学 八取代全氟烷基钴酞菁化合物及其制备方法
JP6608187B2 (ja) * 2015-06-22 2019-11-20 山本化成株式会社 増感色素、半導体電極、光電変換素子および色素増感太陽電池
JP6789195B2 (ja) * 2016-08-24 2020-11-25 サイノラ ゲゼルシャフト ミット ベシュレンクテル ハフツング 特に有機光電子デバイスに使用するための有機分子
CN108017650A (zh) * 2017-03-08 2018-05-11 先尼科化工（上海）有限公司 一种用于滤光片的酞菁化合物及其制备方法和应用方法
EP3611175B1 (en) * 2017-04-07 2022-02-09 Yamamoto Chemicals, Inc. Naphthalocyanine compound, method for producing same, and use thereof
CN110494501B (zh) * 2017-04-07 2022-04-19 山本化成株式会社 酞菁系化合物、及其用途
JP6922361B2 (ja) * 2017-04-07 2021-08-18 Jsr株式会社 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子
JP7431744B2 (ja) * 2018-10-05 2024-02-15 山本化成株式会社 フタロシアニン系化合物、及びその用途
CN112279856B (zh) * 2019-07-24 2021-09-17 南方科技大学 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池
CN112014383B (zh) * 2020-06-30 2024-03-29 杜旭忠 一种用于均相化学发光的光敏剂及其制备方法和应用
WO2022024926A1 (ja) * 2020-07-31 2022-02-03 住友化学株式会社 化合物
CN112812299B (zh) * 2020-12-31 2022-03-29 四川大学 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法
JPWO2022196089A1 (no) * 2021-03-15 2022-09-22

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155780B1 (en) * 1984-03-21 1990-03-28 Imperial Chemical Industries Plc Infra-red absorber
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
EP0346354B1 (en) * 1987-02-13 1992-08-19 The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Substituted phthalocyanines
JPH0730300B2 (ja) * 1988-04-01 1995-04-05 三井東圧化学株式会社 アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料
JPH0756019B2 (ja) * 1988-12-15 1995-06-14 三井東圧化学株式会社 近赤外線吸収剤及びそれを用いた表示・記録材料
JPH07103093B2 (ja) * 1989-01-12 1995-11-08 三井東圧化学株式会社 フタロニトリル系化合物およびその製造方法
DE69228502T2 (de) * 1991-06-19 1999-08-12 Mitsui Chemicals Inc Phthalocyaninverbindungen und ihre Verwendung
DE69228010T2 (de) * 1991-11-08 1999-05-12 Eastman Chem Co Thermoplastische Polymerzusammensetzung welche eine oder mehrere Monomere, im nahen infarot fluoreszierende Verbindungen, darin vermischt enthält
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (ja) * 1994-09-26 1996-04-09 Kanto Chem Co Inc シアノビフェニル誘導体並びにそれらを含む液晶組成物
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Also Published As

Publication number Publication date
EE200200298A (et) 2003-08-15
PL355851A1 (en) 2004-05-31
CA2394891A1 (en) 2001-06-14
WO2001042368A1 (en) 2001-06-14
EP1238016A1 (en) 2002-09-11
NO20022663D0 (no) 2002-06-05
JP2003516421A (ja) 2003-05-13
HUP0301099A2 (hu) 2003-08-28
CZ20021974A3 (cs) 2002-11-13
NO20022663L (no) 2002-08-08
AU2192201A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
HUP0301099A3 (en) Substituted phthalocyanines and their precursors
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
EP1223932A4 (en) COMPOUNDS AND METHODS
EP1146790A4 (en) COMPOUNDS AND METHODS
GB2358375B (en) Tessellation set
GC0000214A (en) 4-Pyridinyl-n-acyl-l-phenyalanines
IL145995A0 (en) Use
GB9913536D0 (en) Use
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
GB2353533B (en) Compounds and inks
TW407616U (en) Assembled and detachable carrier
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
GB9929318D0 (en) Macrocyclic compounds and their use
EP1243609A4 (en) SUCCINIMIDE COMPOUNDS AND THEIR USE
GB9914798D0 (en) Ensure
AU141428S (en) Turnpiece
AU2669201A (en) Taccalonolides and their use
GB9919971D0 (en) Use
GB9828004D0 (en) Use
GB9929064D0 (en) Substituted phthalocyanines and their precursors
GB0025817D0 (en) Substituted phthalocyanines and their precursors
GB9929581D0 (en) Comjpositions and their use
GB9911606D0 (en) Composition and use